Literature DB >> 3667306

Therapeutic use of 90Y microspheres.

G J Ehrhardt1, D E Day.   

Abstract

Glass microspheres 20-30 microns in diameter containing either 31P or 89Y that can be activated by neutron bombardment to 32P or 90Y respectively, have been produced for intra-arterial radiotherapy of liver tumors. The spheres are insoluble in body fluids, non-toxic, and can concentrate in liver tumors of animals by direct injection into the hepatic artery. This gives a higher radiation dose to the tumor than can be achieved with external beam therapy. Trials in rabbits and dogs have proven successful and this product (90Y TheraSpheres) is now entering limited human clinical trials.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3667306     DOI: 10.1016/0883-2897(87)90047-x

Source DB:  PubMed          Journal:  Int J Rad Appl Instrum B        ISSN: 0883-2897


  15 in total

1.  EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds.

Authors:  Francesco Giammarile; Lisa Bodei; Carlo Chiesa; Glenn Flux; Flavio Forrer; Françoise Kraeber-Bodere; Boudewijn Brans; Bieke Lambert; Mark Konijnenberg; Françoise Borson-Chazot; Jan Tennvall; Markus Luster
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07       Impact factor: 9.236

2.  Poly(L-lactic acid) microspheres containing neutron-activatable holmium-165: a study of the physical characteristics of microspheres before and after irradiation in a nuclear reactor.

Authors:  R J Mumper; M Jay
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

3.  Preparation of porous yttrium oxide microparticles by gelation of ammonium alginate in aqueous solution containing yttrium ions.

Authors:  Masakazu Kawashita; Naoko Matsui; Zhixia Li; Toshiki Miyazaki
Journal:  J Mater Sci Mater Med       Date:  2010-03-16       Impact factor: 3.896

Review 4.  Transarterial Radioembolization Agents: a Review of the Radionuclide Agents and the Carriers.

Authors:  Aysheh Alrfooh; Aditi Patel; Sandeep Laroia
Journal:  Nucl Med Mol Imaging       Date:  2021-07-13

Review 5.  Status of colorectal cancer devices: present scenario.

Authors:  Shammy Chandel; Reyhan Akhtar; Pooja Sarotra; Bikash Medhi
Journal:  J Gastrointest Cancer       Date:  2015-06

6.  Can C-arm cone-beam CT detect a micro-embolic effect after TheraSphere radioembolization of neuroendocrine and carcinoid liver metastasis?

Authors:  Olivier Pellerin; MingDe Lin; Nikhil Bhagat; Wenbo Shao; Jean-François Geschwind
Journal:  Cancer Biother Radiopharm       Date:  2013 Jul-Aug       Impact factor: 3.099

7.  Preparation of phosphorus-containing silica glass microspheres for radiotherapy of cancer by ion implantation.

Authors:  M Kawashita; F Miyaji; T Kokubo; Y Suzuki; K Kajiyama
Journal:  J Mater Sci Mater Med       Date:  1999-08       Impact factor: 3.896

Review 8.  Radionuclide therapy revisited.

Authors:  C A Hoefnagel
Journal:  Eur J Nucl Med       Date:  1991

9.  Usefulness of Bremsstrahlung Images after Intra-arterial Y-90 Resin Microphere Radioembolization for Hepatic Tumors.

Authors:  Young Chul Kim; Yun Hwan Kim; Soon Ho Um; Yeon Seok Seo; Eun Kyung Park; Sun Young Oh; You Mie Han; Jae-Gol Choe
Journal:  Nucl Med Mol Imaging       Date:  2010-11-24

Review 10.  The development, commercialization, and clinical context of yttrium-90 radiolabeled resin and glass microspheres.

Authors:  Mark A Westcott; Douglas M Coldwell; David M Liu; Joseph F Zikria
Journal:  Adv Radiat Oncol       Date:  2016-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.